BioSpace News Archive

Business

Recipharm appoints new Director of Business Management

Recipharm, the contract development and manufacturing organisation, has appointed a new director of business management for the USA and Canada to accelerate growth in the region.

February 12, 2019

·

2 min read

BioForest

New Report Finds Nation’s Public Health Emergencies Are Increasing While State Emergency Preparedness Levels Are Mixed; 17 States Score in Top Readiness Tier, 20 States and DC in Middle Tier, 13 States in Lower Tier

Report provides action steps for states to improve emergency preparedness; progress will require action by public health agencies, elected officials and state residents

February 12, 2019

·

4 min read

Agrotop to Present New Line of Smart Poultry Solutions at VIV ASIA 2019

The company will introduce the world’s first chick embryo monitoring system, novel technology for optimal management of poultry farms, as well as Agrotop’s vertical integration solutions

February 12, 2019

·

2 min read

Sagentia: Medical Device Software Development Needs ‘Risk Compass’ for the Digital Age

The complex relationship between opportunity and risk in the connected world poses unprecedented challenges for medical device manufacturers, according to software specialists at product development consultancy Sagentia.

February 12, 2019

·

3 min read

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca Tablets in the United States market, approved by the U.S. Food and Drug Administration.

February 12, 2019

·

2 min read

Bio NC

RTI International Launches Center for Health Care Advancement to Provide Evidence-Based Solutions to Problems in Health Care

Transformational Center Brings 600 Experts to Focus on Higher Quality, Reduced Costs and Improved Outcomes for Patients, Payers and Providers

February 12, 2019

·

2 min read

FDA

Calliditas Therapeutics Granted Orphan Drug Designation by the FDA for Primary Biliary Cholangitis

Calliditas Therapeutics AB announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the company for the treatment of Primary biliary cholangitis (PBC). More information about the ODD has been posted on www.fda.gov.

February 12, 2019

·

3 min read

Drug Development

GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology

Intravitreal administration of GS010 in patients with LHON was safe and well tolerated

February 12, 2019

·

5 min read

Business

Europe’s Peroxfarma Brings its Expertise in Joint Care to America

Peroxfarma, a European pharmaceutical company and a pioneer in joint-care supplements, is bringing its Epaplus “Arthicare” supplements to the American consumer.

February 12, 2019

·

1 min read

Business

Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp

Applied DNA’s CertainT Platform to Power TheraCann’s ETCH BioTrace Seed-to-Sale Tracking System

February 12, 2019

·

5 min read